Last updated: January 7, 2025
Sponsor: St. Jude Children's Research Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neuroblastoma
Retinoblastoma
Cancer (Pediatric)
Treatment
N/AClinical Study ID
NCT06411704
REVAMP
NCI-2024-03931
Ages 18-39 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants enrolled in the St. Jude Lifetime Cohort (SJLIFE), aged 18- 39.
Identifies as low active (self-reports <2 days/week of Physical Activity (PA) for atleast 30 minutes over the past 6 months.
Participant or legal guardian is able and willing to give informed consent.
Internet access
Exclusion
Exclusion Criteria:
- Individuals who cannot speak, read, and/or understand English.
Study Design
Total Participants: 20
Study Start date:
June 06, 2024
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
St. Jude Children's Research Hospital
Memphis, Tennessee 38105
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.